Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nomogram for predicting survival of patients with diffuse large B-cell lymphoma.

Annals of hematology - 1 Jun 2024

Fujii Keiichiro, Inagaki Atsushi, Masaki Ayako, Sugiura Mariko, Suzuki Tomotaka, Ishida Takashi, Kusumoto Shigeru, Iida Shinsuke, Inagaki Hiroshi

Abstract excerpt

The international prognostic index (IPI) system has been widely used to predict prognosis in diffuse large B-cell lymphoma (DLBCL). However, this system categorizes DLBCL patients into four risk groups, and cannot optimize individualized prognosis. In addition, other clinicopathological factors, such as molecular aberrations, are not incorporated into the system. To partly overcome these weak points, we developed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD79 Antigens

Share to Lymphoma, Large B-Cell, Diffuse

Share to Myeloid Differentiation Factor 88

Share to Nomograms

Share to Prognosis

Share to Survival Rate

Source

Identifiers

PMID: 38411628
DOI: 10.1007/s00277-024-05669-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nomogram for predicting survival of patients with diffuse large B-cell lymphoma.PMID 38411628Read ↗

Prediction of Overall Survival Status of Diffuse Large B-Cell Lymphoma Using a Prognostic Classification ModelSemantic proximity Read ↗

Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.Semantic proximity Read ↗

An IPI based immune prognostic model for diffuse large B-cell lymphomaSemantic proximity Read ↗

Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy.Semantic proximity Read ↗

OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Next-generation prognostic assessment for diffuse large B-cell lymphoma.Semantic proximity Read ↗

New nomograms based on treatment outcome and prognostic factors for patients with spinal diffuse large B-cell lymphoma: A population‐based studySemantic proximity Read ↗

Prognostic nomogram for previously untreated adult patients with acute myeloid leukemia.Semantic proximity Read ↗

A novel nomogram for predicting overall survival in peripheral T cell lymphoma patientsSemantic proximity Read ↗

Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma.Semantic proximity Read ↗

Improved Personalized Survival Prediction of Patients With Diffuse Large B-cell Lymphoma Using Gene Expression ProfilingSemantic proximity Read ↗

Classifying DLBCL Subtypes for Optimal Treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.